Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 2026 AL 2040

Environmental risk factors for all-cause dementia, Alzheimer's disease dementia, vascular dementia, and mild cognitive impairment: An umbrella review and meta-analysis

Jones A, Ali MU, Mayhew A, Aryal K, Correia RH, Dash D, Manis DR, Rehman A, O'Connell ME, Taler V, Costa AP, Hogan DB, Wolfson C, Raina P, Griffith L.

Environ Res. 2025 Apr 1;270:121007. doi: 10.1016/j.envres.2025.121007. Epub 2025 Jan 29.

Cardioprotective Glucose-Lowering Agents and Dementia Risk: A Systematic Review and Meta-Analysis

Seminer A, Mulihano A, O'Brien C, Krewer F, Costello M, Judge C, O'Donnell M, Reddin C.

JAMA Neurol. 2025 May 1;82(5):450-460. doi: 10.1001/jamaneurol.2025.0360.

Association between vaccinations and risk of dementia: a systematic review and meta-analysis

Maggi S, Fulöp T, De Vita E, Limongi F, Pizzol D, Di Gennaro F, Veronese N.

Age Ageing. 2025 Oct 30;54(11):afaf331. doi: 10.1093/ageing/afaf331.

The efficacy of cognitive stimulation, cognitive training, and cognitive rehabilitation for people living with dementia: a systematic review and meta-analysis

Paggetti A, Druda Y, Sciancalepore F, Della Gatta F, Ancidoni A, Locuratolo N, Piscopo P, Vignatelli L, Sagliocca L, Guaita A, Secreto P, Stracciari A, Caffarra P, Vanacore N, Fabrizi E, Lacorte E; Italian Dementia Guideline Working Group.

Geroscience. 2025 Feb;47(1):409-444. doi: 10.1007/s11357-024-01400-z. Epub 2024 Nov 1.

The role of the Mediterranean diet in reducing the risk of cognitive impairement, dementia, and Alzheimer's disease: a meta-analysis

Fekete M, Varga P, Ungvari Z, Fekete JT, Buda A, Szappanos Á, Lehoczki A, Mózes N, Grosso G, Godos J, Menyhart O, Munkácsy G, Tarantini S, Yabluchanskiy A, Ungvari A, Győrffy B.

Geroscience. 2025 Jun;47(3):3111-3130. doi: 10.1007/s11357-024-01488-3. Epub 2025 Jan 11.

Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for primary care

Atri A, Dickerson BC, Clevenger C, Karlawish J, Knopman D, Lin PJ, Norman M, Onyike C, Sano M, Scanland S, Carrillo M.

Alzheimers Dement. 2025 Jun;21(6):e14333. doi: 10.1002/alz.14333. Epub 2024 Dec 23.

Structured vs Self-Guided Multidomain Lifestyle Interventions for Global Cognitive Function: The US POINTER Randomized Clinical Trial

Baker LD, Espeland MA, Whitmer RA, Snyder HM, Leng X, Lovato L, Papp KV, Yu M, Kivipelto M, Alexander AS, Antkowiak S, Cleveland M, Day C, Elbein R, Tomaszewski Farias S, Felton D, Garcia KR, Gitelman DR, Graef S, Howard M, Katula J, Lambert K, Matongo O, McDonald AM, Pavlik V, Raman R, Salloway S, Tangney C, Ventrelle J, Wilmoth S, Willliams BJ, Wing R, Woolard N, Carrillo MC.

JAMA. 2025 Aug 26;334(8):681-691. doi: 10.1001/jama.2025.12923.

Disclosure of elevated amyloid status is not associated with long-term suicidality in a preclinical AD trial

Grill JD, Raman R, Flournoy C, Ernstrom K, Pierce A, Smith A, Rosenberg P, Burns J, Karlawish J, Aisen P, Holdridge KC, Mancini M, Sperling R, Sultzer D; A4 Study Team.

Alzheimers Dement. 2025 Feb;21(2):e14623. doi: 10.1002/alz.14623.

Short communication: Evaluating roles of plasma glial fibrillary acidic protein as Alzheimer's disease biomarker in real-world multi-center memory clinics in Thailand

Taweephol T, Pongpitakmetha T, Booncharoen K, Khieukhajee J, Luechaipanit W, Haethaisong T, Chongsuksantikul A, Likitjaroen Y, Thanapornsangsuth P.

J Alzheimers Dis. 2025 Mar;104(2):325-330. doi: 10.1177/13872877251316546. Epub 2025 Feb 9.

[A case of neuronal intranuclear inclusion disease with coexisting Alzheimer's disease biomarker signature in cerebrospinal fluid]

Ono N, Maruyama G, Akaiwa Y, Nakamura T, Tamai C, Sone J, Miyamoto T.

Rinsho Shinkeigaku. 2025 Dec 19;65(12):912-915. doi: 10.5692/clinicalneurol.cn-002153. Epub 2025 Nov 22.

Associations of plasma Neurofilament light chain with sarcopenia and physical capacity in patients with Alzheimer's diseases

Qaisar R, Karim A, Iqbal MS, Alkahtani SA, Ahmad F.

Acta Neurol Belg. 2025 Jun;125(3):691-698. doi: 10.1007/s13760-025-02759-2. Epub 2025 Mar 11.

Pre-treatment subjective sleep quality as a predictive biomarker of tDCS effects in preclinical Alzheimer's disease patients: Secondary analysis of a randomised clinical trial

Lu H, Ni X, Man Chan SS, Cheng CPW, Chan W, Lam LCW.

PLoS One. 2025 Jan 28;20(1):e0317700. doi: 10.1371/journal.pone.0317700. eCollection 2025.

Longitudinally persisting KCNA2-autoantibodies in mild amnestic dementia with Alzheimer´s pathology - Report and literature review

Hansen N, Teegen B, Hirschel S, Fox J, Fitzner D, Wiltfang J, Bartels C.

Behav Brain Res. 2025 Mar 28;482:115437. doi: 10.1016/j.bbr.2025.115437. Epub 2025 Jan 22.

Cognitive and neurodegenerative trajectories of subjective cognitive decline according to baseline biomarkers: Results of the CoSCo study

Hong YJ, Choi SH, Kim S, Jeong JH, Park KH, Wang MJ, Kang S, Yang DW; CoSCo study group.

Alzheimers Dement. 2025 Feb;21(2):e14473. doi: 10.1002/alz.14473. Epub 2024 Dec 28.

Comparison of Methods of Detecting IL-1β in the Blood of Alzheimer's Disease Subjects

Remnitz AD, Hadad R, Keane RW, Dietrich WD, de Rivero Vaccari JP.

Int J Mol Sci. 2025 Jan 20;26(2):831. doi: 10.3390/ijms26020831.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias